https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-14 16:54:252024-03-18 10:38:37Anaphylaxis and Desensitization to Alglucosidase Alfa in late-onset Pompe Disease ten years later after initial enzyme replacement therapy administration: a possible drug-drug interaction of CGRP inhibiting therapies
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-14 16:48:482024-03-18 10:38:37Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne muscular dystrophy (EMBARK): Pivotal Phase 3 Primary results
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-13 10:37:282024-03-18 10:38:37A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-12 16:19:202024-03-18 10:38:37RAINBOWFISH: Primary efficacy and safety data in risdiplam-treated infants with presymptomatic spinal muscular atrophy (SMA)
https://congressoaim2024.it/wp-content/uploads/2024/03/copertina-abstract-2024.png
280
1043
expomeeting
https://congressoaim2024.it/wp-content/uploads/2023/09/trasparente-80x80.png
expomeeting2024-03-11 13:10:562024-03-18 10:38:37Rescue from COVID-19 infection after precipitation of MG crisis in late-onset myasthenia gravis